Schedule 13D ownership disclosure

Idera Pharmaceuticals, Inc.

Security class unavailable · CUSIP: 45168K405

Event date: 2018-09-17

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
4,887,959
Percent of class
18.0000%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001144204-18-050168
Form type
SC 13D/A
Filer
BAKER BROS. ADVISORS LP
CIK
CIK 1263508
Filed
Sep 20, 2018
Reporting period
Sep 17, 2018
Description
Schedule 13D beneficial ownership

Explore SEC Filings Hub